AMANDA GRUBER: Open Payments
NPI 1659880995 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,215 in 39 payments from 20 companies in 2025. Trend: 2023 $1,437 · 2024 $1,538 · 2025 $1,215
Food & beverage: $1,215
| Company | Payments | Amount |
|---|---|---|
| HEARTFLOW, INC. | 2 | $173 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $161 |
| Kestra Medical Technology Services, Inc. | 1 | $149 |
| Novartis Pharmaceuticals Corporation | 6 | $127 |
| Medtronic, Inc. | 1 | $86 |
| Novo Nordisk Inc | 2 | $52 |
| Kowa Pharmaceuticals America, Inc. | 3 | $52 |
| Otsuka America Pharmaceutical, Inc. | 3 | $51 |
| Amgen Inc. | 3 | $48 |
| Esperion Therapeutics, Inc. | 3 | $48 |
Products named: FFRct, JARDIANCE, Assure WCD, LEQVIO, LINQ II, Ozempic, ZORYVE, REXULTI.
Industry payments across TX — which companies pay providers there.
